Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2021	Mar. 31, 2020
Revenue:
Total revenue		$ 202,741	$ 4,657
Operating expenses:
Royalty fees		20,010
Research and development	[1]	12,352	4,118
Sales and marketing	[1]	2,578	437
General and administrative	[1]	6,422	1,650
Depreciation and amortization		3,305	574
Total operating expenses		44,667	6,779
Income (loss) from operations		158,074	(2,122)
Other (income) expense
Other (income) expense		(265)	1,001
Grants and incentives		(3,148)	(1,030)
Total other income		(3,413)	(29)
Net earnings (loss) before income tax		161,487	(2,093)
Provision for income tax		44,266
Net earnings (loss) and comprehensive income (loss) for the period		$ 117,221	$ (2,093)
Net earnings (loss) per share attributable to common shareholders
Basic		$ 0.43	$ (0.01)
Diluted		$ 0.37	$ (0.01)
Weighted-average common shares outstanding
Basic		269,697,212	151,859,924
Diluted		320,282,747	151,859,924
Research Fees
Revenue:
Total revenue		$ 3,986	$ 4,657
Licensing Revenue
Revenue:
Total revenue		20,259
Milestone Payments
Revenue:
Total revenue		7,000
Royalty Revenue
Revenue:
Total revenue		$ 171,496

[1] Exclusive of depreciation and amortization